Ziritaxestat Terminated Phase 2 Trials for Sclerosis, Progressive Systemic Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03976648A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis